Heike Schwende
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-world comparative effectiveness of sacubitril/valsartan versus RAS inhibition alone in patients with de novo heart failure.
Journal: ESC heart failure
Published: June 28, 2024
Early Initiation of Sacubitril/Valsartan in Patients With Acute Heart Failure and Renal Dysfunction: An Analysis of the TRANSITION Study.
Journal: Journal of cardiac failure
Published: April 04, 2023
Health-related quality of life outcomes in PARAGON-HF.
Journal: European journal of heart failure
Published: March 02, 2022
NT-proBNP Response to Sacubitril/Valsartan in Hospitalized Heart Failure Patients With Reduced Ejection Fraction: TRANSITION Study.
Journal: JACC. Heart failure
Published: April 24, 2020
Initiation of sacubitril/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study.
Journal: European journal of heart failure
Published: June 27, 2019
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study.
Journal: European journal of heart failure
Published: December 07, 2018
mTOR inhibition in liver transplantation: how to dose for effective/safe CNI reduction?
Journal: Transplantation proceedings
Published: December 14, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026